A detailed history of Stablepoint Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Stablepoint Partners, LLC holds 135,588 shares of PFE stock, worth $3.86 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
135,588
Previous 134,556 0.77%
Holding current value
$3.86 Million
Previous $4.13 Billion 5.07%
% of portfolio
0.72%
Previous 0.8%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$27.7 - $31.39 $28,586 - $32,394
1,032 Added 0.77%
135,588 $3.92 Billion
Q2 2024

Aug 02, 2024

BUY
$25.26 - $29.6 $846,942 - $992,458
33,529 Added 33.19%
134,556 $4.13 Billion
Q1 2024

Apr 23, 2024

BUY
$25.89 - $29.73 $262,265 - $301,164
10,130 Added 11.14%
101,027 $2.8 Billion
Q4 2023

Feb 12, 2024

BUY
$26.13 - $33.94 $2.38 Million - $3.09 Million
90,897 New
90,897 $2.62 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Stablepoint Partners, LLC Portfolio

Follow Stablepoint Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stablepoint Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stablepoint Partners, LLC with notifications on news.